Supports clinical trials of products evaluating efficacy and safety for new indications or labeling changes to address unmet needs in rare diseases. Encourages collaborative, efficient, and innovative trials to increase approved treatments and positively impact rare disease drug development.
Open to a wide range of organizations including higher education institutions, nonprofits, for-profit organizations, government entities, tribal governments, and foreign organizations. Both domestic and non-domestic entities are eligible to apply.
